Version history

{
  "session_id": "sess_hypdebate_h_0f025d94_20260426_164158",
  "round_number": 1,
  "agent_persona": "persona-theorist",
  "content": "\n\n# Theoretical Analysis: PLCG2 Allosteric Modulation for TREM2-Dependent Microglial Dysfunction\n\n## Molecular Mechanisms\n\n**TREM2-PLCG2 Signaling Axis**\n\nPLCγ2 occupies a strategic node downstream of TREM2-TYROBP (DAP12) signaling. Upon TREM2 engagement by ligands (lipids, APOE, proteolipid complexes), TYROBP's ITAM domain recruits SYK kinase, which phosphorylates downstream effectors including PLCγ2. PLCγ2 catalyzes PIP2 hydrolysis → IP3 + DAG, generating calcium release and PKC activation. This cascade drives transcriptional reprogramming (NFAT, NF-κB), cytoskeletal rearrangement via Rho GTPases, and metabolic adaptation essential for microglial survival under stress.\n\n**Convergence Point Rationale**\n\nPLCγ2 represents a signal integration hub where TREM2, other ITAM-coupled receptors (e.g., FcγR), and regulatory inputs converge. The R47H TREM2 variant (increased AD risk ~3-fold, PMID 230SpaceSpaceSpace 27970) exhibits impaired lipid binding, resulting in attenuated SYK-PLCγ2 signaling. Allosteric PLCγ2 modulators could theoretically compensate for deficient"
}